Profil bibliographique

Lidwine W. Tick

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

111Publications signalées

3896Citations signalées

0Affiliations récentes

Domaines associés

Venous Thromboembolism Diagnosis and ManagementAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCancer survivorship and care

Publications récentes

Accès ouvert 2026 articleOpenAlex

Treatment Patterns, Outcomes and Survival Trends in T‐Cell Prolymphocytic Leukemia: A Nationwide Population‐Based Study in the Netherlands

Mirian Brink, Arie C. van der Spek, Jeanette K. Doorduijn, Koen de Heer et autres

0 citationsEuropean Journal Of Haematology

Accès ouvert 2026 articleOpenAlex

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands – A nationwide study of drug usage and treatment outcomes

Benno Diekmann, Carolien M. Woolthuis, Maarten F. Corsten, David de Leeuw et autres

0 citationsEuropean Journal of Cancer

Accès ouvert 2026 articleOpenAlex

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study

Marie José Kersten, M Dreyling, Kim M. Linton, Dana Chitu et autres

0 citationsHaematologica

Accès ouvert 2026 articleOpenAlex

Flow Cytometry‐Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non‐Intensive Chemotherapy

Lukas H. Haaksma, Tom Reuvekamp, Kasper J Croese, M L Muijtjens et autres

0 citationsAmerican Journal of Hematology

Accès ouvert 2026 articleOpenAlex

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia

Niels Westra, Elena Ropero Cerro, Edwin Schilder, Marjolijn N Lub-de Hooge et autres

1 citationBlood Neoplasia

Accès ouvert 2025 conference-abstractOpenAlex

Long term follow-up and results of retreatement after obinutuzumab-venetoclax in first-line CLL patients with coexisting conditions

Mark‐David Levin, Sabina Kersting, Kazem Nasserinejad, Johan A. Dobber et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia

Kathelijn Verdeyen, Tom Reuvekamp, Walter J. F. M. van der Velden, Bas J. Wouters et autres

2 citationsHaematologica

Accès ouvert 2025 articleOpenAlex

Associations of various medical nutrition therapy strategies with body composition, and physical and clinical outcomes in acute myeloid leukemia patients undergoing intensive remission-induction treatment: A multicenter prospective correlational study

Rianne van Lieshout, Lidwine W. Tick, Erik A.M. Beckers, Willemijn Biesbroek et autres

4 citationsClinical Nutrition ESPEN

2024 conference-abstractOpenAlex

Improved Efficacy with Response- and MRD-Guided Ibrutinib-Obinutuzumab (IO) Intensification after Ibrutinib-Venetoclax (IV) in First Line Chronic Lymphocytic Leukemia (CLL) Patients: Primary Analysis of the HOVON 158/Next STEP Phase 2 Trial

Mark‐David Levin, Sabina Kersting, Julie Dubois, Bronno van der Holt et autres

5 citationsBlood

Accès ouvert 2024 articleOpenAlex

Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome

Gerwin Huls, Dana Chiţu, Lidwine W. Tick, Rinske Boersma et autres

0 citationsAnnals of Hematology

Accès ouvert 2024 articleOpenAlex

Patency and reflux in relation to postthrombotic syndrome: a subanalysis of the Ultrasound-Accelerated Catheter-Directed Thrombolysis Versus Anticoagulation for the Prevention of Post-Thrombotic Syndrome trial

Ruben D Hupperetz, Aaron F J Iding, Jorinde van Laanen, Rutger Brans et autres

8 citationsJournal of Thrombosis and Haemostasis

Accès ouvert 2024 articleOpenAlex

Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry

Afke Ekels, Lonneke V. van de Poll‐Franse, Djamila E. Issa, Mels Hoogendoorn et autres

2 citationsAnnals of Hematology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.